Recombinant Human MMP28 Protein, N-His

Introduction to Recombinant Human MMP28 Protein

Recombinant Human Matrix Metalloproteinase 28 (MMP28) is a protein that plays a crucial role in various physiological and pathological processes. It is a member of the matrix metalloproteinase family, which consists of enzymes that are involved in the breakdown of extracellular matrix components. MMP28 is also known as epilysin, matrilysin-2, or metalloproteinase-28, and it is encoded by the MMP28 gene located on chromosome 19 in humans.

Structure of Recombinant Human MMP28 Protein

Recombinant Human MMP28 Protein is a 57-kDa protein that is composed of 490 amino acids. It contains a signal peptide, a prodomain, a catalytic domain, a hinge region, and a hemopexin-like domain. The catalytic domain is responsible for the proteolytic activity of MMP28, while the hemopexin-like domain is involved in substrate binding. The prodomain is important for the regulation of MMP28 activity, as it needs to be cleaved to activate the enzyme. The hinge region provides flexibility to the protein, allowing it to interact with different substrates.

Activity of Recombinant Human MMP28 Protein

Recombinant Human MMP28 Protein is a zinc-dependent endopeptidase that is primarily involved in the degradation of extracellular matrix proteins such as collagen, fibronectin, and laminin. It is expressed in various tissues, including the skin, lung, and reproductive organs. MMP28 has been shown to play a role in tissue remodeling, wound healing, and immune response. It also has a role in cancer progression and metastasis, as it can promote tumor invasion and angiogenesis.

The activity of MMP28 is tightly regulated by various mechanisms. The prodomain of MMP28 needs to be cleaved to activate the enzyme, and this can be done by other MMPs or by extracellular proteases such as plasmin. In addition, the activity of MMP28 can be inhibited by tissue inhibitors of metalloproteinases (TIMPs) and other endogenous inhibitors. This tight regulation ensures that MMP28 is only active when needed and prevents excessive degradation of the extracellular matrix.

Application of Recombinant Human MMP28 Protein

Recombinant Human MMP28 Protein has various applications in both research and clinical settings. In research, it is commonly used as a tool to study the role of MMP28 in different physiological and pathological processes. It can be used to investigate the role of MMP28 in tissue development, wound healing, and immune response. In addition, recombinant MMP28 can be used to identify potential substrates and inhibitors for this enzyme.

In the clinical setting, recombinant MMP28 has potential applications in the diagnosis and treatment of various diseases. Due to its involvement in cancer progression, MMP28 has been proposed as a potential biomarker for cancer diagnosis and prognosis. In addition, MMP28 inhibitors are being developed as potential therapeutics for cancer and other diseases where MMP28 plays a role, such as arthritis and cardiovascular diseases.

Conclusion

In summary, Recombinant Human MMP28 Protein is a 57-kDa protein that plays a crucial role in tissue remodeling, wound healing, and immune response. It is composed of a signal peptide, prodomain, catalytic domain, hinge region, and hemopexin-like domain. The activity of MMP28 is tightly regulated by various mechanisms, and it has potential applications in both research and clinical settings. Further studies on this enzyme may lead to a better understanding of its role in health and disease and the development of novel therapeutics.